150 North Wacker Drive
Suite 2360
Chicago, IL 60606
847-381-5465 Phone
847-381-4606 Fax

User Information

Create New Account

Lost Password


Quick Links

LCDs and LCAs
by Contractor

PLA Codes

Laboratory Fee Schedule


Physician Fee Schedule


OPPS Fee Schedule


ASC Fee Schedule


APC Codes


DRG Codes


ASP Drug Pricing Files

October 2023
July 2023

CMS Transmittals

CodeMap® LCD-L33418


Printer Friendly Version

LCD for Assays for Vitamins and Metabolic Function (L33418)
See related Articles:
A56485-Billing and Coding: Assays for Vitamins and Metabolic Function

Contractor Information

Contractor Name: Palmetto GBA - Full list of policies of this Medicare Contractor

Contractor Number: 11202

Contractor Type: MAC B

LCD Information

LCD ID Number: L33418 Status: R- Retired

LCD Title: Assays for Vitamins and Metabolic Function

Geographic Jurisdiction: South Carolina Other Jurisdictions

Original Determination Effective Date: 10/01/2015

Original Determination Ending Date: 01/28/2023

Revision Effective Date: 12/10/2020

Revision End Date: 01/28/2023

CMS National Coverage Policy:

Title XVIII of the Social Security Act, §1862 (a)(1)(A) allows coverage and payment for only those services that are considered to be reasonable and necessary for the diagnosis or treatment of illness or injury or to improve the functioning of a malformed body member.

42 Code of Federal Regulations (CFR) §410.32 indicates that diagnostic tests are payable only when ordered by the physician who is treating the beneficiary for a specific medical problem and who uses the results in such treatment.

Federal Register, Vol. 66, No. 226, November 23, 2001, pp. 58788–58890 addresses coverage and administrative policies for clinical diagnostic laboratory services.

CMS Internet-Only Manual, Pub 100-02, Medicare Benefit Policy Manual, Chapter 6, §20.4.3 Coverage of Outpatient Diagnostic Services Furnished on or Before December 31, 2009

CMS Internet-Only Manual, Pub 100-03, Medicare National Coverage Determinations Manual, Chapter 1, Part 4, §230.19 Levocarnitine for Use in the Treatment of Carnitine Deficiency in ESRD Patients

Sorry, you need to login or register to view additional sections of this Medicare policy.


All information on this web site is compiled directly from information obtained from the Center for Medicare and Medicaid Services (CMS) and from its Contractors.

CodeMap® has made every reasonable effort to ensure the accuracy of the information contained on this web site. However, the ultimate responsibility for correct coding and claims submission lies with the provider of services. CodeMap® makes no representation, warranty, or guarantee that this compilation of Medicare information is error-free or that the use of this information will result in Medicare coverage and subsequent payment of claims. Final coverage and payment of claims are subject to many factors exclusively controlled by CMS and its contractors.

No part of this web page or data displayed may be redistibuted or used without the express written consent of Wheaton Partners, LLC.

12/08/2023 02:37:05

CodeMap® is a Registered Trademark of Wheaton Partners, LLC.